These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23401175)

  • 1. Mechanistic basis of phenothiazine-driven inhibition of Tau aggregation.
    Akoury E; Pickhardt M; Gajda M; Biernat J; Mandelkow E; Zweckstetter M
    Angew Chem Int Ed Engl; 2013 Mar; 52(12):3511-5. PubMed ID: 23401175
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.
    Wischik CM; Edwards PC; Lai RY; Roth M; Harrington CR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11213-8. PubMed ID: 8855335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
    Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R
    Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation.
    Crowe A; James MJ; Lee VM; Smith AB; Trojanowski JQ; Ballatore C; Brunden KR
    J Biol Chem; 2013 Apr; 288(16):11024-37. PubMed ID: 23443659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent tau-targeted clinical strategies for the treatment of Alzheimer's disease.
    Lee HE; Lim D; Lee JY; Lim SM; Pae AN
    Future Med Chem; 2019 Aug; 11(15):1845-1848. PubMed ID: 31517533
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of a Tau-Targeted Drug Delivery System Using a Multifunctional Nanoscale Metal-Organic Framework for Alzheimer's Disease Therapy.
    Zhao J; Yin F; Ji L; Wang C; Shi C; Liu X; Yang H; Wang X; Kong L
    ACS Appl Mater Interfaces; 2020 Oct; 12(40):44447-44458. PubMed ID: 32897042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylene Blue Inhibits Formation of Tau Fibrils but not of Granular Tau Oligomers: A Plausible Key to Understanding Failure of a Clinical Trial for Alzheimer's Disease.
    Soeda Y; Saito M; Maeda S; Ishida K; Nakamura A; Kojima S; Takashima A
    J Alzheimers Dis; 2019; 68(4):1677-1686. PubMed ID: 30909223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and mechanism of action of tau aggregation inhibitors.
    Cisek K; Cooper GL; Huseby CJ; Kuret J
    Curr Alzheimer Res; 2014; 11(10):918-27. PubMed ID: 25387336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Lest we forget you--methylene blue...".
    Schirmer RH; Adler H; Pickhardt M; Mandelkow E
    Neurobiol Aging; 2011 Dec; 32(12):2325.e7-16. PubMed ID: 21316815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand polarizability contributes to tau fibril binding affinity.
    Jensen JR; Cisek K; Honson NS; Kuret J
    Bioorg Med Chem; 2011 Sep; 19(17):5147-54. PubMed ID: 21803586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins.
    Taniguchi S; Suzuki N; Masuda M; Hisanaga S; Iwatsubo T; Goedert M; Hasegawa M
    J Biol Chem; 2005 Mar; 280(9):7614-23. PubMed ID: 15611092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylene Blue Inhibits Caspases by Oxidation of the Catalytic Cysteine.
    Pakavathkumar P; Sharma G; Kaushal V; Foveau B; LeBlanc AC
    Sci Rep; 2015 Sep; 5():13730. PubMed ID: 26400108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease.
    Harrington CR; Storey JM; Clunas S; Harrington KA; Horsley D; Ishaq A; Kemp SJ; Larch CP; Marshall C; Nicoll SL; Rickard JE; Simpson M; Sinclair JP; Storey LJ; Wischik CM
    J Biol Chem; 2015 Apr; 290(17):10862-75. PubMed ID: 25759392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Caenorhabditis elegans model of tau hyperphosphorylation: induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau.
    Brandt R; Gergou A; Wacker I; Fath T; Hutter H
    Neurobiol Aging; 2009 Jan; 30(1):22-33. PubMed ID: 17590239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer's Disease.
    Chen Q; Du Y; Zhang K; Liang Z; Li J; Yu H; Ren R; Feng J; Jin Z; Li F; Sun J; Zhou M; He Q; Sun X; Zhang H; Tian M; Ling D
    ACS Nano; 2018 Feb; 12(2):1321-1338. PubMed ID: 29364648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different inhibitory response of cyanidin and methylene blue for filament formation of tau microtubule-binding domain.
    Hattori M; Sugino E; Minoura K; In Y; Sumida M; Taniguchi T; Tomoo K; Ishida T
    Biochem Biophys Res Commun; 2008 Sep; 374(1):158-63. PubMed ID: 18619417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine-Independent Inhibition of Alzheimer's Disease-like Paired Helical Filament Assembly by Leuco-Methylthioninium (LMT).
    Al-Hilaly YK; Pollack SJ; Rickard JE; Simpson M; Raulin AC; Baddeley T; Schellenberger P; Storey JMD; Harrington CR; Wischik CM; Serpell LC
    J Mol Biol; 2018 Oct; 430(21):4119-4131. PubMed ID: 30121297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation and detection of tau aggregation with small-molecule ligands.
    Chang E; Honson NS; Bandyopadhyay B; Funk KE; Jensen JR; Kim S; Naphade S; Kuret J
    Curr Alzheimer Res; 2009 Oct; 6(5):409-14. PubMed ID: 19874263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments.
    Schweers O; Mandelkow EM; Biernat J; Mandelkow E
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8463-7. PubMed ID: 7667312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau Biology and Tau-Directed Therapies for Alzheimer's Disease.
    Bakota L; Brandt R
    Drugs; 2016 Mar; 76(3):301-13. PubMed ID: 26729186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.